Clinical Trials Browser

Phase 1/2 × Lung Diseases × atezolizumab × Clear all

NCT07407933 2026-02-12

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Lung Diseases, Thoracic Neoplasms, Small Cell Lung Carcinoma